Parameter
| Biomarker | AR & CD44 | Full name | Androgen Receptor & Cluster of Differentiation 44 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis & therapy selection |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Tissue (ChIP-seq, IHC) | ||
| Pathobiological Mechanisms | AR transcriptionally represses CD44; inverse correlation; low AR associated with advanced high-grade disease | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | AR-CD44 axis may guide prognosis assessment & treatment decisions | ||||